Trump pro­pos­al ta­pers Medicare pro­tec­tion for cer­tain drugs if drug­mak­ers don't tem­per pric­ing

In its op­po­si­tion to the in­dus­try stan­dard of re­lent­less and of­ten ex­or­bi­tant drug price hikes, the Trump ad­min­is­tra­tion seems to be do­ing more than huff­ing and puff­ing. Af­ter threat­en­ing to switch to a sys­tem that pegs US prices against cheap­er rates abroad ahead of the mid-term elec­tions last month, HHS out­lined a pro­pos­al on Mon­day that could rule out cer­tain drugs from be­ing in­clud­ed as part of guar­an­teed Medicare cov­er­age, if their mak­ers con­tin­ue to hike prices un­de­terred.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER